Uppsala on the 26th of October. The theme for the autum meeting isInfectious Diseases.
Time:
13.00-17.00 followed by mingle with light food
Venue:
Elite Hotel Academia
Program:
Justin Wilkins, Occams
PK/PD of the novel P. falciparum translation elongation factor 2 inhibitor cabamiquine.
Ayorinde Adehin, Mahidol Oxford Tropical Medicine Research Unit, Bangkok
Fexinidazole in Chagas disease: minimizing toxicity and optimizing efficacy.
TBC, Pharmetheus
Model-informed sustained release formulation development of 5-Flucytosine to treat cryptococcal meningitis.
Wendy Chu, Netherlands Cancer Institute & Uppsala University
Model-Based Characterization of the Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Burden in Post-Kala Azar Dermal Leishmaniasis Patients.
Yu-Jou Lin, Uppsala University
Multistate model of tuberculosis treatment outcomes and identification of predictors.
Lina Keutzer, Uppsala University
Linezolid, an old drug for new bugs - model-assisted optimization of linezolid dosing in resistant tuberculosis patients based on pharmacokinetics, efficacy and safety information.